Literature DB >> 31330042

Choosing Among Common Data Models for Real-World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products.

Sebastian Schneeweiss1, Jeff S Brown2, Andrew Bate3, Gianluca Trifirò4, Dorothee B Bartels5.   

Abstract

Many real-world data analyses use common data models (CDMs) to standardize terminologies for medication use, medical events and procedures, data structures, and interpretations of data to facilitate analyses across data sources. For decision makers, key aspects that influence the choice of a CDM may include (i) adaptability to a specific question; (ii) transparency to reproduce findings, assess validity, and instill confidence in findings; and (iii) ease and speed of use. Organizing CDMs preserve the original information from a data source and have maximum adaptability. Full mapping data models, or preconfigured rules systems, are easy to use, since all raw codes are mapped to medical constructs. Adaptive rule systems grow libraries of reusable measures that can easily adjust to preserve adaptability, expedite analyses, and ensure study-specific transparency.
© 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Year:  2019        PMID: 31330042     DOI: 10.1002/cpt.1577

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Using and improving distributed data networks to generate actionable evidence: the case of real-world outcomes in the Food and Drug Administration's Sentinel system.

Authors:  Jeffrey S Brown; Judith C Maro; Michael Nguyen; Robert Ball
Journal:  J Am Med Inform Assoc       Date:  2020-05-01       Impact factor: 4.497

2.  National health information technology priorities for research: A policy and development agenda.

Authors:  Teresa Zayas-Cabán; Kevin J Chaney; Donald W Rucker
Journal:  J Am Med Inform Assoc       Date:  2020-04-01       Impact factor: 4.497

Review 3.  Integrating real-world data to accelerate and guide drug development: A clinical pharmacology perspective.

Authors:  Xiaochen Zhao; Shahed Iqbal; Ivelisse L Valdes; Mark Dresser; Sandhya Girish
Journal:  Clin Transl Sci       Date:  2022-08-07       Impact factor: 4.438

Review 4.  Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework.

Authors:  Rishi J Desai; Michael E Matheny; Kevin Johnson; Keith Marsolo; Lesley H Curtis; Jennifer C Nelson; Patrick J Heagerty; Judith Maro; Jeffery Brown; Sengwee Toh; Michael Nguyen; Robert Ball; Gerald Dal Pan; Shirley V Wang; Joshua J Gagne; Sebastian Schneeweiss
Journal:  NPJ Digit Med       Date:  2021-12-20

5.  Perceived Risk of Re-Identification in OMOP-CDM Database: A Cross-Sectional Survey.

Authors:  Yae Won Tak; Seng Chan You; Jeong Hyun Han; Soon-Seok Kim; Gi-Tae Kim; Yura Lee
Journal:  J Korean Med Sci       Date:  2022-07-04       Impact factor: 5.354

6.  From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding.

Authors:  Nicolas H Thurin; Romin Pajouheshnia; Giuseppe Roberto; Caitlin Dodd; Giulia Hyeraci; Claudia Bartolini; Olga Paoletti; Hedvig Nordeng; Helle Wallach-Kildemoes; Vera Ehrenstein; Elena Dudukina; Thomas MacDonald; Giorgia De Paoli; Maria Loane; Christine Damase-Michel; Anna-Belle Beau; Cécile Droz-Perroteau; Régis Lassalle; Jorieke Bergman; Karin Swart; Tania Schink; Clara Cavero-Carbonell; Laia Barrachina-Bonet; Ainhoa Gomez-Lumbreras; Maria Giner-Soriano; María Aragón; Amanda J Neville; Aurora Puccini; Anna Pierini; Valentina Ientile; Gianluca Trifirò; Anke Rissmann; Maarit K Leinonen; Visa Martikainen; Sue Jordan; Daniel Thayer; Ieuan Scanlon; Mary E Georgiou; Marianne Cunnington; Morris Swertz; Miriam Sturkenboom; Rosa Gini
Journal:  Clin Pharmacol Ther       Date:  2021-11-26       Impact factor: 6.903

7.  The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives.

Authors:  Valeria Belleudi; Filomena Fortinguerra; Francesca R Poggi; Serena Perna; Renata Bortolus; Serena Donati; Antonio Clavenna; Anna Locatelli; Marina Davoli; Antonio Addis; Francesco Trotta
Journal:  Front Pharmacol       Date:  2021-06-23       Impact factor: 5.810

Review 8.  Different Strategies to Execute Multi-Database Studies for Medicines Surveillance in Real-World Setting: A Reflection on the European Model.

Authors:  Rona Gini; Miriam C J Sturkenboom; Janet Sultana; Alison Cave; Annalisa Landi; Alexandra Pacurariu; Giuseppe Roberto; Tania Schink; Gianmario Candore; Jim Slattery; Gianluca Trifirò
Journal:  Clin Pharmacol Ther       Date:  2020-05-05       Impact factor: 6.875

9.  Real-world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK-based electronic health records database.

Authors:  Anouchka Seesaghur; Natalia Petruski-Ivleva; Victoria Banks; Jocelyn Ruoyi Wang; Pattra Mattox; Edwin Hoeben; Joe Maskell; David Neasham; Shannon L Reynolds; George Kafatos
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-11-21       Impact factor: 2.890

10.  Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments.

Authors:  Sebastian Schneeweiss; Elisabetta Patorno
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.